Iron Absorption From Infant Formula and Iron Drops in Infants (MJAU-studien)

NCT ID: NCT01216709

Last Updated: 2020-03-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

72 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-10-31

Study Completion Date

2012-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Iron deficiency (ID) affects up to 25% of Swedish infants and severe ID is associated with cognitive and behavioral problems. To avoid this, iron supplements or iron-fortified infant foods are recommended for infants. However, the optimal iron dose and mode of delivery have not yet been established. This is a concern as excessive iron intake may impair growth and increase morbidity in iron-sufficient infants. Previous studies have suggested that iron-fortified foods may have different effects than iron supplements. In this study, the investigators will investigate whether the mode of iron administration (supplementation vs. fortification) and the amount consumed (high intakes vs. low intakes) affect iron absorption, iron utilization, and zinc absorption in healthy term non-iron-deficient 6-month-old infants.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infant Dietary Supplements Food, Fortified

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

iron drops

Group Type EXPERIMENTAL

ferrous sulfate

Intervention Type DIETARY_SUPPLEMENT

6.3 mg iron from iron drops and 0.3 mg iron from infant formula with no added iron (0.5 mg iron/L) for 45 days

iron-fortified formula (2.3 mg iron/L)

Group Type EXPERIMENTAL

iron-fortified infant formula (2.3 mg iron/L)

Intervention Type OTHER

1.2 mg iron from iron-fortified infant formula (2.3 mg iron/L) for 45 days

iron-fortified formula (12.4 mg iron /L)

Group Type EXPERIMENTAL

iron-fortified infant formula (12.4 mg iron/L)

Intervention Type OTHER

6.6 mg iron from iron-fortified infant formula (12.4 mg iron/L) for 45 days

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ferrous sulfate

6.3 mg iron from iron drops and 0.3 mg iron from infant formula with no added iron (0.5 mg iron/L) for 45 days

Intervention Type DIETARY_SUPPLEMENT

iron-fortified infant formula (12.4 mg iron/L)

6.6 mg iron from iron-fortified infant formula (12.4 mg iron/L) for 45 days

Intervention Type OTHER

iron-fortified infant formula (2.3 mg iron/L)

1.2 mg iron from iron-fortified infant formula (2.3 mg iron/L) for 45 days

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 6-7 months of age at the start of intervention
* healthy at enrollment
* full-term (\>37 gestational weeks at birth)
* birth weight \>2500 g
* predominantly bottle-fed at recruitment

Exclusion Criteria

* iron deficiency at enrollment
* previous or current use of iron supplements
Minimum Eligible Age

6 Months

Maximum Eligible Age

7 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Swiss Federal Institute of Technology

OTHER

Sponsor Role collaborator

University of California, Davis

OTHER

Sponsor Role collaborator

Umeå University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Magnus Domellöf

MD, PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Magnus Domellöf, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Umeå University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Clinical Sciences, Pediatrics, Umeå University Hospital

Umeå, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Iron absorption in infants

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Iron Deficiency (ID) in Infants
NCT02484274 COMPLETED NA
Iron Babies Pilot Supplementation Trial
NCT04751994 COMPLETED PHASE3
Baby Iron Bioavailability Study
NCT03754543 COMPLETED NA